Recent Press Releases

Lilly to Showcase Data from its Alzheimer's Disease Portfolio at the Alzheimer's Association International Conference 2014 (AAIC 2014)

Highlights include additional analyses from Phase 3 and ongoing open-label studies, discovery research on the potential use of combination therapy and data on the impact of beta-amyloid imaging on

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc.

Baxter Names Chief Financial Officers for New Biopharmaceutical Spin-Off and Baxter International Inc. DEERFIELD, Ill., JULY 7, 2014 - Baxter International Inc. (NYSE:BAX) announced that upon...

Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology

Valeant Pharmaceuticals Completes Acquisition Of PreCision Dermatology PR Newswire -8 July 2014 - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE"). THERE CAN BE NO CERTAINTY THAT ANY FIRM...

NASCAR Driver Ryan Reed Finishes Fourth at the Subway Firecracker 250 at Daytona International Speedway

On and off the track, Reed shows that diabetes doesn't slow him down

INDIANAPOLIS and ALEXANDRIA, Va.

Technical Pulse on Pharma Stocks -- Research on Pfizer, Hospira, Endo Intl., and Nektar Therapeutics

Editor Note: For more information about this release, please scroll to bottom.

LONDON, July 7, 2014

Pershing Square Proposes Independent Slate For Allergan Board of Directors

NEW YORK--(BUSINESS WIRE)-- Pershing Square Capital Management, L.P. ("Pershing Square") today announced a slate of six highly experienced, independent directors for the board of...

GSK receives EU marketing authorisation for Mekinist™ (trametinib) for patients with unresectable or metastatic melanoma with a BRAF V600 mutation

GSK receives EU marketing authorisation for Mekinist™ (trametinib) for patients with unresectable or metastatic melanoma with a BRAF V600 mutation GlaxoSmithKline plc (LSE/NYSE: GSK) today...

Cipla to expand global footprint, plans investment in its UK subsidiary

Cipla to expand global footprint, plans investment in its UK subsidiary India, Mumbai, 7th July 2014: Cipla Limited, a global healthcare company, today announced in collaboration with the UK...

Alnylam Elects Amy Schulman to its Board of Directors

CAMBRIDGE, Mass., Jul 02, 2014 (BUSINESS WIRE) --Alnylam Pharmaceuticals, Inc . ALNY +1.46% , a leading RNAi therapeutics company, announced today the election of Amy W. Schulman to its Board of...

Novartis begins shipment of seasonal influenza vaccines to US market for the 2014-2015 season

CAMBRIDGE, Mass., July 2, 2014 /PRNewswire/ -- Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2014-2015 season. Novartis...

Teva Files Citizen Petition with the U.S. Food and Drug Administration (FDA) Regarding the Complexity of COPAXONE® (glatiramer acetate) Following the Agency's Guidance

Teva Files Citizen Petition with the U.S. Food and Drug Administration (FDA) Regarding the Complexity of COPAXONE® (glatiramer acetate) Following the Agency's Guidance Teva includes new gene...

Actavis Completes Acquisition of Furiex Pharmaceuticals

Actavis Completes Acquisition of Furiex Pharmaceuticals DUBLIN, July 2, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that its subsidiary Forest Laboratories, LLC has successfully...

Achilles Receives Cigna Foundation Grant to Study Effect of Running on Autism

--$100,000 World of Difference grant will fund research lacking today

BLOOMFIELD, Conn., July 1, 2014

Amgen Receives FDA Breakthrough Therapy Designation For Investigational BiTE® Antibody Blinatumomab In Acute Lymphoblastic Leukemia

Breakthrough Designation Reinforces Significant Unmet Need in the Treatment of This Highly Aggressive Cancer

THOUSAND OAKS, Calif.

Novartis statement on employee oversight charges in Japan

Novartis Pharmaceuticals said today that although NPKK has not yet received official notification, NPKK understands that the Tokyo District Prosecutor's Office (TPO) has publicly disclosed that...

More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug

More MSF patients with DR-TB gain access to dramatically cheaper version of life-saving drug Patients & MSF doctors elated as MCC approval for MSF to use generic linezolid paves the way for...

Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO(R) (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation

Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO(R) (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation...

Producers of High Quality, Low Cost Generic Medicines Organize, "Coalition of Affordable Care" is formed - U.S.-based India First Group to Lead the Charge

Producers of High Quality, Low Cost Generic Medicines Organize, "Coalition of Affordable Care" is formed - U.S.-based India First Group to Lead the Charge WASHINGTON, Jun 25, 2014 (BUSINESS...